FULVESTRANT ACCORD, FULVESTRANT INTAS (Accord Healthcare Pty Ltd)
Product name
FULVESTRANT ACCORD, FULVESTRANT INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 working days (225)
Active ingredients
fulvestrant
Registration type
New generic medicine
Indication
FULVESTRANT ACCORD, FULVESTRANT INTAS (solution for injection) is indicated for the treatment of postmenopausal women with hormone-receptor positive, locally advanced or metastatic breast cancer who have progressive disease following prior tamoxifen therapy.